Table 6c.
Time to frequent relapses: During the follow-up period
| Group | No. of Patients | No. of Patients with Frequent Relapses | No. of Patients with Steroid Resistance as Competing Event | No. of Patients Censored | Median (95% CI) (days) | Hazard Ratio (95% CI) |
|---|---|---|---|---|---|---|
| MMF | 33 | 16 | 1 | 16 | 461.0 (224.0 to not reached) | 2.373 (0.77 to 7.32) |
| Placebo | 17 | 4 | 0 | 13 | not reached (278.0 to not reached) |